Nodality scores $3.5M for personal diagnostics

Nodality, a biotech company that makes diagnostics focused on cell pathways, has brought in $3.5 million of an expected $10 million round of equity, according to a filing with the SEC. Based in South San Francisco, its backers include Kleiner Perkins Caufield & ByersMaverick Capital and TPG Biotechnology.

Next Story:
Previous Story:

Tags: , , ,

Photo of Camille Ricketts

About the Author, Camille Ricketts

Camille is the lead writer for GreenBeat. She came to VentureBeat from Google where she worked on its traditional platforms team, particularly in TV. Before that, she was a reporter for the Wall Street Journal in New York and London. Follow her on Twitter at @camillericketts, and follow VentureBeat on Twitter at @venturebeat.

blog comments powered by Disqus